Article

COST-EFFECTIVENESS ANALYSIS OF HLA-B*15:02 SCREENING BEFORE TREATMENT OF EPILEPSY IN INDONESIA

2023-10-27

Abstract excerpt

<h4>Aim: </h4> Adverse skin reactions due to drugs such as Stevens Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) occur in 3% of people receiving anti epileptic drugs (AED). Although SJS/TEN has a low incidence, the mortality and morbidity rates are high. Indonesia has not adopted HLA-B*1502 screening prior to administration of carbamazepine (CBZ), although previous studies found a relationship betwee...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 971d0504-96cf-585f-a9f2-8eba43a3f013
DOI: 10.22541/au.169842788.81763052/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

COST-EFFECTIVENESS ANALYSIS OF HLA-B*15:02 SCREENING BEFORE TREATMENT OF EPILEPSY IN INDONESIADOI 10.22541/au.169842788.81763052/v1Read

Cost-effectiveness analysis of genotyping for HLA-B*15:02 in Indonesian patients with epilepsy using a generic model.Semantic proximity Read

Cost‐effectiveness of screening for HLA‐B*1502 prior to initiation of carbamazepine in epilepsy patients of Asian ancestry in the United StatesSemantic proximity Read

Economic Evaluation of HLA-B*15:02 Genotyping for Asian Australian Patients With Epilepsy.Semantic proximity Read

Cost minimization of HLA-B*1502 screening before prescribing carbamazepine in Thailand.Semantic proximity Read

Cost-effectiveness of HLA-B*1502 genotyping in adult patients with newly diagnosed epilepsy in Singapore.Semantic proximity Read

Usage Pattern of Carbamazepine and Associated Severe Cutaneous Adverse Reactions in Singapore Following Implementation of HLA-B*15:02 Genotyping as Standard-of-CareSemantic proximity Read

Coupling Genotyping and Computational Modeling in Prediction of Anti-epileptic Drugs that cause Stevens Johnson Syndrome and Toxic Epidermal Necrolysis for Carrier of HLA-B*15:02.Semantic proximity Read

Clinical Pharmacogenetics Implementation Consortium guidelines for HLA-B genotype and carbamazepine dosing.Semantic proximity Read

Unraveling the genetic link: an umbrella review on HLA-B*15:02 and antiepileptic drug-induced Stevens-Johnson syndrome/toxic epidermal necrolysis.Semantic proximity Read

Unravelling the Genetic Link: An Umbrella Review on HLA-B∗15:02 and Anti-Epileptic Drug-induced Stevens–Johnson Syndrome / Toxic Epidermal NecrolysisSemantic proximity Read

Impact on carbamazepine usage and cutaneous adverse reactions before and after the reimbursement of HLA-B*1502 genotyping in Taiwan, 2000-2017: A nationwide longitudinal study.Semantic proximity Read

HLA genotype testing for carbamazepine, oxcarbazepine and eslicarbazepine: A guideline developed by the UK Centre of Excellence in Regulatory Science and Innovation in Pharmacogenomics (CERSI-PGx).Semantic proximity Read